Trials / Conditions / Stage IIIB Primary Peritoneal Cancer

Stage IIIB Primary Peritoneal Cancer

13 registered clinical trials studyying Stage IIIB Primary Peritoneal Cancer.

Status	Trial	Sponsor	Phase
Withdrawn	PET Imaging of Ovarian Carcinoma With 18F-FSPG NCT02872519	Vanderbilt-Ingram Cancer Center	EARLY_Phase 1
Withdrawn	Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Perito NCT02833506	Roswell Park Cancer Institute	Phase 1
Terminated	IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, o NCT03029611	University of Washington	Phase 2
Withdrawn	Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian NCT02470559	Barbara Ann Karmanos Cancer Institute	Phase 1
Completed	Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Pri NCT01606241	Mayo Clinic	Phase 1
Terminated	Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherap NCT01275664	Gynecologic Oncology Group	N/A
Completed	OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Ca NCT00857545	Gynecologic Oncology Group	Phase 2
Completed	Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritone NCT01080521	Gynecologic Oncology Group	—
Completed	Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian NCT02311907	Alliance for Clinical Trials in Oncology	Phase 3
Completed	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Isl NCT01010126	National Cancer Institute (NCI)	Phase 2
Terminated	YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal NCT00899093	Gynecologic Oncology Group	—
Completed	Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian NCT00262847	National Cancer Institute (NCI)	Phase 3
Completed	Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442	Gynecologic Oncology Group	—